These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7562429)

  • 1. Dose dependency of the kinetics of dextrans in rats: effects of molecular weight.
    Mehvar R; Robinson MA; Reynolds JM
    J Pharm Sci; 1995 Jul; 84(7):815-8. PubMed ID: 7562429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats.
    Mehvar R; Robinson MA; Reynolds JM
    J Pharm Sci; 1994 Oct; 83(10):1495-9. PubMed ID: 7533835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus.
    Mehvar R; Reynolds JM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):662-9. PubMed ID: 7679734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of hepatic accumulation of dextrans in isolated perfused rat livers.
    Mehvar R
    Drug Metab Dispos; 1997 May; 25(5):552-6. PubMed ID: 9152593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats.
    Mehvar R; Shepard TL
    J Pharm Sci; 1992 Sep; 81(9):908-12. PubMed ID: 1279158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-induction reduction in the hepatic accumulation of 70-kDA dextran: role of hyperglycemia and hypoinsulinemia.
    Mehvar R; Reynolds J
    J Pharm Sci; 1994 Jul; 83(7):1020-5. PubMed ID: 7525920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption characteristics of dextrans with different molecular weights from the liver surface membrane in rats: implications for targeting to the liver.
    Nishida K; Sato N; Sasaki H; Nakamura J
    J Drug Target; 1996; 4(3):141-50. PubMed ID: 8959486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice.
    Kaneo Y; Uemura T; Tanaka T; Kanoh S
    Biol Pharm Bull; 1997 Feb; 20(2):181-7. PubMed ID: 9057983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: dose-dependent pharmacokinetics in rats.
    Zhang X; Mehvar R
    Int J Pharm; 2001 Oct; 229(1-2):173-82. PubMed ID: 11604270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats.
    Nishida K; Tomiyama N; Mukai T; Nakashima M; Sasaki H; Nakamura J
    Eur J Pharm Biopharm; 2004 Nov; 58(3):705-11. PubMed ID: 15451548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of fluorescein-labelled dextran (150 kD) in isolated perfused livers from control and diabetic rats.
    Mehvar R; Reynolds JM; Shepard TL
    Life Sci; 1991; 49(23):1699-706. PubMed ID: 1719328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of glutathione-dextran macromolecular conjugate in mice.
    Kaneo Y; Uemura T; Tanaka T; Kanoh S; Matsuoka A
    Biol Pharm Bull; 1995 Nov; 18(11):1544-7. PubMed ID: 8593476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
    Ito Y; Ise A; Sugioka N; Takada K
    Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
    Zhang X; Mehvar R
    J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.
    Nishida K; Kuma A; Fumoto S; Nakashima M; Sasaki H; Nakamura J
    J Pharm Pharmacol; 2005 Aug; 57(8):1073-7. PubMed ID: 16102265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreal elimination kinetics of large molecular weight FITC-labeled dextrans in albino rabbits using a novel microsampling technique.
    Dias CS; Mitra AK
    J Pharm Sci; 2000 May; 89(5):572-8. PubMed ID: 10756322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose toxicokinetics of aluminum in the rat.
    Wilhelm M; Zhang XJ; Hafner D; Ohnesorge FK
    Arch Toxicol; 1992; 66(10):700-5. PubMed ID: 1290402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
    Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
    J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.